BackGSK Plc Overview

GSK Plc Long Term Debt

Latest long-term debt for GSK: $14B.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$13.86B

Peer trimmed avg / median

Loading

GSK Plc Long Term Debt History

Loading

GSK Plc vs. peers: Long Term Debt Comparison

Loading

GSK Plc Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

GSK Plc (GSK) FAQ

GSK Plc (GSK) currently reports a long-term debt of $14B as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore GSK Plc's long-term debt history and peer comparisons.

GSK Plc's long-term debt changed from $0 to $14B (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

GSK Plc reported $14B in long-term debt as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $14B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for GSK Plc, and consider following GSK for alerts when major investors trade the stock.

GSK Plc is classified in the Healthcare sector. On long-term debt, it currently shows $14B. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing GSK with unrelated industries.